Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Lilja

Showing results (61-70 of 306) with videos related to

Pageof 31
Sort By:
Urology|March 20, 2016
Author ReplyAndrew J Vickers, James A Eastham, Peter T Scardino, et al.
European Urology|January 6, 2015
Opportunistic testing versus organized prostate-specific antigen screening: outcome after 18 years in the Göteborg randomized population-based prostate cancer screening trialRebecka Arnsrud Godtman, Erik Holmberg, Hans Lilja, et al.
European Urology|September 26, 2024
Re: Early Prostate Cancer Deaths Among Men with Higher vs Lower Genetic RiskSigrid V Carlsson, Hans Lilja, Andrew J Vickers, et al.
Analytical Chemistry|November 16, 2006
Intact free prostate-specific antigen and free and total human glandular kallikrein 2. Elimination of assay interference by enzymatic digestion of antibodies to F(ab')2 fragmentsVille Väisänen, Mari T Peltola, Hans Lilja, et al.
European Urology|May 30, 2025
Reply to Francesco Montorsi, Giorgio Gandaglia, Francesco Barletta, and Alberto Briganti's Letter to the Editor re: Andreas Josefsson, Marianne Månsson, Kimia Kohestani, et al. Performance of 4Kscore as a Reflex Test to Prostate-specific Antigen in the GÖTEBORG-2 Prostate Cancer Screening Trial. Eur Urol 2024;86:223-9Andreas Josefsson, Sigrid V Carlsson, Hans Lilja, et al.
Urology|August 2, 2003
Evolution of free, complexed, and total serum prostate-specific antigen and their ratios during 1 year of follow-up of men with febrile urinary tract infectionBjörn Zackrisson, Peter Ulleryd, Gunnar Aus, et al.
Carcinogenesis|May 14, 2015
miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosisOlivia Larne, Zandra Hagman, Hans Lilja, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 17, 2011
Evaluation of a new immunoassay for cystatin C, based on a double monoclonal principle, in men with normal and impaired renal functionNoora Ristiniemi, Caroline Savage, Laila Bruun, et al.
Analytical Chemistry|November 1, 2017
Clinical-Scale Cell-Surface-Marker Independent Acoustic Microfluidic Enrichment of Tumor Cells from BloodCecilia Magnusson, Per Augustsson, Andreas Lenshof, et al.
Nephron. Physiology|July 8, 2003
Serum cystatin C is a more sensitive and more accurate marker of glomerular filtration rate than enzymatic measurements of creatinine in renal transplantationAnders Christensson, Jana Ekberg, Anders Grubb, et al.
Pageof 31

Showing results (61-70 of 306) with videos related to

Sort By:
Pageof 31
Urology|March 20, 2016
Author ReplyAndrew J Vickers, James A Eastham, Peter T Scardino, et al.
European Urology|January 6, 2015
Opportunistic testing versus organized prostate-specific antigen screening: outcome after 18 years in the Göteborg randomized population-based prostate cancer screening trialRebecka Arnsrud Godtman, Erik Holmberg, Hans Lilja, et al.
European Urology|September 26, 2024
Re: Early Prostate Cancer Deaths Among Men with Higher vs Lower Genetic RiskSigrid V Carlsson, Hans Lilja, Andrew J Vickers, et al.
Analytical Chemistry|November 16, 2006
Intact free prostate-specific antigen and free and total human glandular kallikrein 2. Elimination of assay interference by enzymatic digestion of antibodies to F(ab')2 fragmentsVille Väisänen, Mari T Peltola, Hans Lilja, et al.
European Urology|May 30, 2025
Reply to Francesco Montorsi, Giorgio Gandaglia, Francesco Barletta, and Alberto Briganti's Letter to the Editor re: Andreas Josefsson, Marianne Månsson, Kimia Kohestani, et al. Performance of 4Kscore as a Reflex Test to Prostate-specific Antigen in the GÖTEBORG-2 Prostate Cancer Screening Trial. Eur Urol 2024;86:223-9Andreas Josefsson, Sigrid V Carlsson, Hans Lilja, et al.
Urology|August 2, 2003
Evolution of free, complexed, and total serum prostate-specific antigen and their ratios during 1 year of follow-up of men with febrile urinary tract infectionBjörn Zackrisson, Peter Ulleryd, Gunnar Aus, et al.
Carcinogenesis|May 14, 2015
miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosisOlivia Larne, Zandra Hagman, Hans Lilja, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 17, 2011
Evaluation of a new immunoassay for cystatin C, based on a double monoclonal principle, in men with normal and impaired renal functionNoora Ristiniemi, Caroline Savage, Laila Bruun, et al.
Analytical Chemistry|November 1, 2017
Clinical-Scale Cell-Surface-Marker Independent Acoustic Microfluidic Enrichment of Tumor Cells from BloodCecilia Magnusson, Per Augustsson, Andreas Lenshof, et al.
Nephron. Physiology|July 8, 2003
Serum cystatin C is a more sensitive and more accurate marker of glomerular filtration rate than enzymatic measurements of creatinine in renal transplantationAnders Christensson, Jana Ekberg, Anders Grubb, et al.
Pageof 31